meglumine antimonate


Also found in: Encyclopedia.

meglumine antimonate

A drug used in treating leishmaniasis.
See also: meglumine
Mentioned in ?
References in periodicals archive ?
Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs.
Retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimonate. Re vista da Sociadade Brasileire de Medicana Tropical 2005;38:213-7.
Clinical efficacy of intramuscular meglumine antimonate alone and in combination with intralezyonel meglumine antimonate in the treatment of old wold cutaneous lesishmaniasis.
tropica to glucantime (meglumine antimonate) an antileishmanial agent, was also attributed to higher GSH levels (3).
Standard therapy for all forms of the disease is pentavalent antimony of sodium stibogluconate (Pentostam, GlaxoSmithKline) or meglumine antimonate (Glucantime, Aventis).
The patient's initial treatment included gluteal injections of meglumine antimonate at a dosage of 20 mg antimony/kg/d intramuscularly for a total course of 21 days (LOE=5).
The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis.
de Lalla F, Pellizer G, Gradoni L et al.Acute pancreatitis associated with the administration of meglumine antimonate. Clin Infect Dis.